au.\*:("MAYES, Maureen")
Results 1 to 25 of 82
Selection :
Endothelin and endothelin receptor antagonists in systemic rheumatic diseaseMAYES, Maureen D.Arthritis and rheumatism. 2003, Vol 48, Num 5, pp 1190-1199, issn 0004-3591, 10 p.Article
Scleroderma epidemiologyMAYES, Maureen D.Rheumatic diseases clinics of North America. 2003, Vol 29, Num 2, issn 0889-857X, v, 239-254 [17 p.]Article
Overlap of systemic sclerosis and rheumatoid arthritisALKASSAB, Firas; MAYES, Maureen D.Journal of rheumatology. 2007, Vol 34, Num 7, pp 1593-1594, issn 0315-162X, 2 p.Article
Abnormal responses to endothelial agonists in Raynaud's phenomenon and sclerodermaFREEDMAN, Robert R; GIRGIS, Reda; MAYES, Maureen D et al.Journal of rheumatology. 2001, Vol 28, Num 1, pp 119-121, issn 0315-162XArticle
Effect of temperature and modulators of protein tyrosine kinase activity on the reactivity of isolated venules in secondary Raynaud's phenomenonFURSPAN, Philip B; MAYES, Maureen D; FREEDMAN, Robert R et al.Journal of rheumatology. 2001, Vol 28, Num 10, pp 2263-2268, issn 0315-162XArticle
Outcome measurements in scleroderma : Results from a delphi exerciseGAZI, Hashim; POPE, Janet E; EMERY, Paul et al.Journal of rheumatology. 2007, Vol 34, Num 3, pp 501-509, issn 0315-162X, 9 p.Article
The Disability Index of the health assessment Questionnaire is a predictor and correlate of outcome in the high-dose versus low-dose penicillamine in systemic sclerosis trialCLEMENTS, Philip J; WENG KEE WONG; MEDSGER, Thomas A et al.Arthritis and rheumatism. 2001, Vol 44, Num 3, pp 653-661, issn 0004-3591Article
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of Oral Type I Collagen Treatment in Patients With Diffuse Cutaneous Systemic Sclerosis I. Oral Type I Collagen Does Not Improve Skin in All Patients, but May Improve Skin in Late-Phase DiseasePOSTLETHWAITE, Arnold E; WENG KEEWONG; MORELAND, Larry et al.Arthritis and rheumatism. 2008, Vol 58, Num 6, pp 1810-1822, issn 0004-3591, 13 p.Article
Predictors and outcomes of scleroderma renal crisis: The high-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis trialDEMARCO, Paul J; WEISMAN, Michael H; MORELAND, Larry et al.Arthritis and rheumatism. 2002, Vol 46, Num 11, pp 2983-2989, issn 0004-3591, 7 p.Article
Effect of Increased Pigmentation on the Antifibrotic Response of Human Skin to UV-Al PhototherapyWANG, Frank; GARZA, Luis A; FISHER, Gary J et al.Archives of dermatology (1960). 2008, Vol 144, Num 7, pp 851-858, issn 0003-987X, 8 p.Article
Disease and symptom burden in systemic sclerosis : A patient perspectiveSUAREZ-ALMAZOR, Maria E; KALLEN, Michael A; ROUNDTREE, Aimee K et al.Journal of rheumatology. 2007, Vol 34, Num 8, pp 1718-1726, issn 0315-162X, 9 p.Article
The prevalence of undiagnosed pulmonary arterial hypertension in subjects with connective tissue disease at the secondary health care level of community-based rheumatologists (the UNCOVER study)WIGLEY, Fredrick M; LIMA, Joao A. C; MAYES, Maureen et al.Arthritis and rheumatism. 2005, Vol 52, Num 7, pp 2125-2132, issn 0004-3591, 8 p.Article
High-dose versus low-dose d-penicillamine in early diffuse systemic sclerosis trial: Lessons learnedCLEMENTS, Philip J; SEIBOLD, James R; STEEN, Virginia et al.Seminars in arthritis and rheumatism. 2004, Vol 33, Num 4, pp 249-263, issn 0049-0172, 15 p.Article
Multicriteria decision analysis methods with 1000Minds for developing systemic sclerosis classification criteriaJOHNSON, Sindhu R; NADEN, Raymond P; GABRIELLI, Armando et al.Journal of clinical epidemiology. 2014, Vol 67, Num 6, pp 706-714, issn 0895-4356, 9 p.Article
Independent Replication and Metaanalysis of Association Studies Establish TNFSF4 as a Susceptibility Gene Preferentially Associated with the Subset of Anticentromere-positive Patients with Systemic SclerosisCOUSTET, Baptiste; BOUAZIZ, Matthieu; KOUMAKIS, Eugenie et al.Journal of rheumatology. 2012, Vol 39, Num 5, pp 997-1003, issn 0315-162X, 7 p.Article
Cyclophosphamide versus placebo in scleroderma lung diseaseTASHKIN, Donald P; ELASHOFF, Robert; SEIBOLD, James R et al.The New England journal of medicine. 2006, Vol 354, Num 25, pp 2655-2666, issn 0028-4793, 12 p.Article
Skin thickness score as a predictor and correlate of outcome in systemic sclerosis: High-dose versus low-dose penicillamine trialCLEMENTS, Philip J; HURWITZ, Eric L; MEDSGER, Thomas A et al.Arthritis and rheumatism. 2000, Vol 43, Num 11, pp 2445-2454, issn 0004-3591Article
MQX-503, a Novel Formulation of Nitroglycerin, Improves the Severity of Raynaud's Phenomenon : A Randomized, Controlled TrialCHUNG, Lorinda; SHAPIRO, Lee; SMITH, Edwin et al.Arthritis and rheumatism. 2009, Vol 60, Num 3, pp 870-877, issn 0004-3591, 8 p.Article
Measures of Response in Clinical Trials of Systemic Sclerosis: The Combined Response Index for Systemic Sclerosis (CRISS) and Outcome Measures in Pulmonary Arterial Hypertension Related to Systemic Sclerosis (EPOSS)KHANNA, Dinesh; DISTLER, Oliver; LOVELL, Daniel et al.Journal of rheumatology. 2009, Vol 36, Num 10, pp 2356-2361, issn 0315-162X, 6 p.Conference Paper
Effects of 1-year treatment with cyclophosphamide on outcomes at 2 years in scleroderma lung diseaseTASHKIN, Donald P; ELASHOFF, Robert; SEIBOLD, James R et al.American journal of respiratory and critical care medicine. 2007, Vol 176, Num 10, pp 1026-1034, issn 1073-449X, 9 p.Article
Impact of oral cyclophosphamide on health-related quality of life in patients with active scleroderma lung disease : Results from the scleroderma lung studyKHANNA, Dinesh; XIAOHONG YAN; RILEY, David J et al.Arthritis and rheumatism. 2007, Vol 56, Num 5, pp 1676-1684, issn 0004-3591, 9 p.Article
Clinical, immunologic, and genetic features of familial systemic sclerosisASSASSI, Shervin; ARNETT, Frank C; REVEILLE, John D et al.Arthritis and rheumatism. 2007, Vol 56, Num 6, pp 2031-2037, issn 0004-3591, 7 p.Article
Vascular and connective tissue histopathologic alterations of the female lower genital tract in sclerodermaDOSS, Barbara J; QURESHI, Faisal; MAYES, Maureen D et al.Journal of rheumatology. 2002, Vol 29, Num 7, pp 1384-1387, issn 0315-162XArticle
Risk of malignancy in scleroderma : A population-based cohort studyCHATTERJEE, Soumya; DOMBI, George W; SEVERSON, Richard K et al.Arthritis and rheumatism. 2005, Vol 52, Num 8, pp 2415-2424, issn 0004-3591, 10 p.Article
Minocycline is not effective in systemic sclerosis: Results of an open-label multicenter trialMAYES, Maureen D; O'DONNELL, Daniel; ROTHFIELD, Naomi F et al.Arthritis and rheumatism. 2004, Vol 50, Num 2, pp 553-557, issn 0004-3591, 5 p.Article